In addition, although not conducted in NSCLC, other studies have indicated that a combination of RDW with tumor markers (CA125 in endometrial cancer [27]; CEA in colorectal cancer [28]) could have better efficacy in prognosis than used individually. This evidence concerns the gene CEACAM5 and non-small cell lung carcinoma.